4D pharma plc: 4D pharma appoints John Doyle as Chief Financial Officer

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces

Related Keywords

United States ,Julie Seidel ,John Doyle ,Duncan Peyton ,Lynne Dardanell ,Amryt Pharma ,Dominic Wilson ,Philip Davies James Fischer ,Neil Hunter Michelle Boxall ,Bryan Garnier Co ,Early Phase Division ,Stern Investor Relations Inc ,Chiasma Inc ,Image Box Communications ,Nasdaq ,Merck Co Inc ,University Of Massachusetts ,Hologic Inc ,Investor Relations At Verastem Inc ,Chief Financial Officer ,Chief Executive Officer ,Vice President ,Investor Relations ,Verastem Inc ,Financial Planning Analysis ,Simplivity Corp ,Hewlett Packard Enterprises ,Business Unit Financial Planning Analysis ,Irritable Bowel Syndrome ,Capital Markets Nominated Adviser ,Joint Broker ,Davies James Fischer ,Corporate Finance ,Corporate Broking ,Limited Joint Broker ,Vbox Communications ,Hunter Michelle Boxall ,Pharma ,Ppoints ,John ,Moyle ,Chief ,Financial ,Officer ,